We are reporting a new case of lethal strongyloidiasis of an HIV-infected patient. After discussion of the actual classification, dividing strongyloidiasis in an intestinal form, hyperinfestation and systemic strongyloidiasis, we try to apply this classification on the aquired immunodeficiency syndrome by doing a review of the published cases so far. This review shows the limits of the current classification. Treatement actually consists of thiabenadazole or ivermectine, but survival is scarce. A systematic research of strongyloidiasis seems to be useful in HIV-infected patients living or having lived in endemic aereas.